Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Deep Learning Model Predicts Pathological Complete Response of Esophageal Squamous Cell Carcinoma Following Neoadjuvant Immunochemotherapy

NCT07088354 is registered in ClinicalTrials.gov with Tongji Hospital as lead sponsor.

NCT NCT07088354
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07088354 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Deep Learning Model Predicts Pathological Complete Response of Esophageal Squamous Cell Carcinoma Following Neoadjuvant Immunochemotherapy
Lead sponsor
Tongji Hospital
Phase
Observational
Overall status
Recruiting
Start date
March 1, 2025
Completion date
December 1, 2026
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

deep learning, esophageal squamous cell carcinoma, neoadjuvant immunochemotherapy, pathological complete response